Proton Pump Inhibitors For Gastric Acid Therapy Market: Enteric-Coated Formulations, GERD Management, and Mucosal Healing Driving Growth
Escalating global prevalence of gastroesophageal reflux disease (GERD), rising incidence of peptic ulcer disease and NSAID-induced gastric mucosal injury, and broad over-the-counter (OTC) accessibility of acid-suppressing medications are driving sustained growth across the global Proton Pump Inhibitors For Gastric Acid Therapy Market. Proton pump inhibitors (PPIs)—comprising oral...
0 Σχόλια 0 Μοιράστηκε 2 Views 0 Προεπισκόπηση